May 19, 2016
Personalizing Therapy for Patients With CML
Video Categories: CMLRelated Videos
July 25, 2018
How MSI and TMB Factor into Current Biomarker Testing Panels
Dr Sanjiv Agarwala discusses the usefulness of MSI and TMB as novel biomarkers for various cancer types. His argument is that the first FDA approval of a therapy based on MSI rather than tumor type makes this biomarker useful, but TMB is not yet ready for “prime time.”
August 15, 2016
Carcinoid Heart Disease
Richard Parker, MD, provides an overview of this condition, which is common on patients with carcinoid syndrome.